NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Gilead Sciences  »  News  »   Gilead Sciences

  News for Gilead Sciences

  • Business

Gilead to allow 5 Indian firms to sell hepatitis generics in 90 countries

Multinational American drug maker Gilead Sciences was set to join hands with at least five Indian generic pharmaceutical companies and allow them to manufacture and sell cheaper versions of its new......

3 generic HIV/AIDS drugs: Ranbaxy-Gilead pact

Drug major Ranbaxy said Tuesday it has entered into an agreement with US-headquartered Gilead Sciences to manufacture and market three new generic HIV/AIDS drugs in India and developing......

Ranbaxy, US co tie up for HIV drug

Ranbaxy Laboratories Ltdsaid on Monday it has entered into a licensing agreement with US-based Gilead Sciences Inc for manufacturing and marketing of Active Pharmaceutical Ingredientand......

4 Indian firms get AIDS drug licence

US-based Gilead Sciences has licensed its anti-AIDS drug Tenofovir to four Indian drug makers - Alchem, J V Chemicals, Shasun Chemicals and Aurobindo Pharma - and is looking for another three, in a......

Strides Arcolab ties up with US co for HIV drugs

Strides Arcolab Ltd has signed an agreement with US-based bio-pharmaceutical company, Gilead Sciences, for manufacturing and distributing generic versions of anti-HIV drugs Truvada and Viread.The......
  Web results for Gilead Sciences
GSK receives European marketing authorisation to expand indication for Volibris® in treatment of pulmonary arterial hypertension

GSK today announced that the European Commission has approved a variation to expand the current therapeutic indication for Volibris® (ambrisentan)... ...
Beta Adrenergic Blocking Agents, Calcium Channel Blocker, Antiarrhythmic Agents, and Anticoagulants) - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends, and Forecast

From the Wires Nov. 23, 2015 01:10 PM LONDON , Nov. 23, 2015 /PRNewswire/ -- This report on the hypertrophic cardiomyopathy therapeutics... ...
Bristol-Myers signs deal with U.N. group for generic hepatitis C drug

Reuters (Reuters) - A United Nations-backed organization working to cut the price of HIV drugs said it had signed a deal with Bristol-Myers... ...
Pipeline of Atrial Fibrillation Therapeutics for H2 2015 Studied in New Research Report

/PRNewswire/ -- New market research "Atrial Fibrillation - Pipeline Review, H2 2015" covers global therapeutic landscape of Atrial Fibrillation... ...
HIV therapeutics market will crawl to $15.3 bn by 2023

The treatment landscape is expected to experience a paradigm shift towards integrase inhibitor drugs and single-tablet regimens The value of the... ...

Related Tags

  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Related Pages

gilead sciences
Gilead Sciences


Top Coverage News

Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z